Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : Phase 3 study
Foresee Pharmaceuticals Reports Positive DSMB Review for Casppian Phase 3 CPP Trial
02/04/2026 | Companies
biopharmaceutical research,
CAMCEVI,
Casppian Phase 3,
central precocious puberty,
clinical trial update,
controlled-release formulation,
CPP,
Data and Safety Monitoring Board,
drug safety,
DSMB safety review,
Foresee Pharmaceuticals,
FP-001,
GnRH therapy,
leuprolide 42 mg,
long-acting injectable,
multinational clinical trial,
pediatric drug development,
pediatric endocrinology,
pharmacokinetics,
Phase 3 study,
prostate cancer treatment,
regulatory milestone
Viatris Champions Global Mental Health Awareness and Innovative Care in 2024
10/21/2025 | Companies
art therapy,
awareness,
Brazil,
capacity building,
clinical guidelines,
community outreach,
Effexor,
Egypt,
emotional wellbeing,
generalized anxiety disorder,
government partnership,
healthcare education,
mental health,
mental health access,
mental health advocacy,
mental health campaigns,
Mexico,
Mind on Canvas,
Museo Reina Sofía,
patient support,
Phase 3 study,
primary care,
psychiatric care,
public health,
research,
stigma reduction,
training,
treatment development,
Türkiye,
United Arab Emirates,
Viatris Foundation,
wellbeing,
World Mental Health Day
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com